The pathophysiological understanding of interstitial lung diseases (ILDs) has made impressive progress over the last years leading to approved therapies and an increasing number of promising drug candidates currently tested in clinical trials. In our online seminar, an interdisplinary panel of leaders in the field will present their novel data on target identification, large scale tissue omics and image omics in the ILDs.
Contact
Nicole Schneider